ESGEN Acquisition Corp. Schedules Shareholder Vote for Business Combination

TL;DR

ESGEN SPAC meeting March 26 to vote on merger. Big news incoming!

AI Summary

ESGEN Acquisition Corp. announced on March 6, 2024, that it will hold a special meeting of its stockholders on March 26, 2024, to vote on a proposed business combination. The company is a special purpose acquisition company (SPAC) incorporated in the Cayman Islands.

Why It Matters

This filing indicates a significant step towards ESGEN Acquisition Corp. completing its intended merger or acquisition, which could lead to the public trading of a new entity.

Risk Assessment

Risk Level: medium — SPACs inherently carry risk due to the uncertainty of completing a business combination and the potential for shareholder redemptions.

Key Numbers

• 001-40927 — SEC File Number (Identifies the company's filings with the SEC.)

Key Players & Entities

• ESGEN Acquisition Corp. (company) — Registrant
• March 6, 2024 (date) — Date of Report
• March 26, 2024 (date) — Date of Special Meeting
• Cayman Islands (location) — Jurisdiction of Incorporation

FAQ

Key Financial Figures

• $0.0001 — nsisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemab
• $11.50 — ordinary share at an exercise price of $11.50 EASCW The Nasdaq Stock Market LLC
• $5,000,001 — requirement that ESGEN retain at least $5,000,001 of net tangible assets following the re
• $27,600 — uthorized share capital of ESGEN from US$27,600 divided into 250,000,000 Class A ordina
• $11.44 — at a redemption price of approximately $11.44 per share, for an aggregate redemption
• $15,292,557.28 — , for an aggregate redemption amount of $15,292,557.28. Following such redemptions, 71,793 Cl
• $821,811.92 — ponsor remain outstanding, representing $821,811.92 cash in trust that will be available to

Filing Documents

• d784419d8k.htm (8-K) — 90KB
• 0001193125-24-062445.txt ( ) — 263KB
• eascu-20240306.xsd (EX-101.SCH) — 3KB
• eascu-20240306_def.xml (EX-101.DEF) — 14KB
• eascu-20240306_lab.xml (EX-101.LAB) — 24KB
• eascu-20240306_pre.xml (EX-101.PRE) — 15KB
• d784419d8k_htm.xml (XML) — 7KB

Forward-Looking Statements

Forward-Looking Statements This Current Report on Form 8-K contains forward-looking statements within the meaning of section 27A of the Securities Act of 1933, as amended (the " Securities Act "), and Section 21E of the Exchange Act of 1934, as amended, that are based on beliefs and assumptions and on information currently available to ESGEN and Sunergy. Forward-looking statements include, but are not limited to, statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions. The words "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "will" and similar references to future periods may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements may include, for example, statements about ESGEN's and Sunergy's ability to effectuate the proposed Business Combination discussed in this Current Report on Form 8-K; the benefits of the Business Combination; the future financial performance of the combined company following the transactions; changes in ESGEN's or Sunergy's strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects, the ability to raise additional funds prior to the closing of the Business Combination and plans and objectives of management. These forward-looking statements are based on information available as of the date of this Current Report on Form 8-K, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing ESGEN's or Sunergy's views as of any subsequent date, and none of ESGEN or Sunergy undertakes any obligation to update forward-looking statements to reflect events or circumstances after the date they were

SIGNATURES

SIGNATURES Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ESGEN ACQUISITION CORPORATION Dated: March 7, 2024 By: /s/ Nader Daylami Name: Nader Daylami Title: Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR